Skip to main content

Tri Locum Partners LP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1826434 NEW YORK, NY

Position in TEVA

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$30,752,760
-$14,060,586 QoQ
Shares Held
1,021,008
-28.9% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
4.32%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2021
CallValue
$4,414,410
CallShares
445,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Tri Locum Partners LP holds $72,480,762 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (42.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TEVA
Teva Pharmaceutical Industries Ltd
This page
1,021,008 $30,752,760

All Filings in TEVA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,752,760 1,021,008
2025-12-31 $44,813,346 1,435,865
2025-06-30 $34,305,138 2,046,846
2025-03-31 $16,307,692 1,061,008
2024-12-31 $53,405,476 2,423,116
2024-09-30 $49,658,380 2,755,737
2024-06-30 $41,442,488 2,550,307
2024-03-31 $31,270,412 2,216,188
2023-12-31 $18,732,857 1,794,335
2023-09-30 $26,855,508 2,632,893
2023-06-30 $8,326,448 1,105,770
2023-03-31 $8,959,501 1,012,373
2022-09-30 $5,516,756 683,613
2021-06-30 $4,414,410 445,900